IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:IVG - NL0015000LU4 - Common Stock
18.825 EUR
+0 (+0.03%)
IVG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 109 industry peers in the Machinery industry. IVG has a medium profitability rating, but doesn't score so well on its financial health evaluation. IVG has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year IVG was profitable.
IVG had a positive operating cash flow in the past year.
Of the past 5 years IVG 4 years were profitable.
IVG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 1.73%, IVG perfoms like the industry average, outperforming 41.28% of the companies in the same industry.
IVG's Return On Equity of 12.39% is fine compared to the rest of the industry. IVG outperforms 73.39% of its industry peers.
The Return On Invested Capital of IVG (4.53%) is comparable to the rest of the industry.
IVG had an Average Return On Invested Capital over the past 3 years of 3.91%. This is below the industry average of 8.86%.
The last Return On Invested Capital (4.53%) for IVG is above the 3 year average (3.91%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
IVG's Profit Margin of 2.17% is on the low side compared to the rest of the industry. IVG is outperformed by 61.47% of its industry peers.
In the last couple of years the Profit Margin of IVG has grown nicely.
IVG's Operating Margin of 5.00% is in line compared to the rest of the industry. IVG outperforms 41.28% of its industry peers.
In the last couple of years the Operating Margin of IVG has grown nicely.
IVG's Gross Margin of 16.49% is on the low side compared to the rest of the industry. IVG is outperformed by 90.83% of its industry peers.
In the last couple of years the Gross Margin of IVG has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
The number of shares outstanding for IVG has been reduced compared to 1 year ago.
IVG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IVG has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.77, we must say that IVG is in the distress zone and has some risk of bankruptcy.
IVG has a Altman-Z score (1.77) which is in line with its industry peers.
IVG has a debt to FCF ratio of 14.82. This is a negative value and a sign of low solvency as IVG would need 14.82 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 14.82, IVG is doing worse than 71.56% of the companies in the same industry.
A Debt/Equity ratio of 1.35 is on the high side and indicates that IVG has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.35, IVG is doing worse than 82.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.62
WACC7.28%
2.3 Liquidity
A Current Ratio of 1.98 indicates that IVG should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.98, IVG is in the better half of the industry, outperforming 73.39% of the companies in the same industry.
IVG has a Quick Ratio of 1.40. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.40, IVG is doing good in the industry, outperforming 78.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
The earnings per share for IVG have decreased strongly by -23.43% in the last year.
IVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.82% yearly.
The Revenue has decreased by -7.24% in the past year.
IVG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.06% yearly.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
3.2 Future
IVG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
Based on estimates for the next years, IVG will show a small growth in Revenue. The Revenue will grow by 4.30% on average per year.
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
IVG is valuated correctly with a Price/Earnings ratio of 14.05.
83.49% of the companies in the same industry are more expensive than IVG, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of IVG to the average of the S&P500 Index (27.00), we can say IVG is valued slightly cheaper.
The Price/Forward Earnings ratio is 8.73, which indicates a very decent valuation of IVG.
IVG's Price/Forward Earnings ratio is rather cheap when compared to the industry. IVG is cheaper than 90.83% of the companies in the same industry.
IVG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.05 | ||
| Fwd PE | 8.73 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IVG is valued a bit cheaper than 77.98% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 67.89% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.76 | ||
| EV/EBITDA | 5.58 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y1.82%
EPS Next 3Y8.15%
5. Dividend
5.1 Amount
IVG has a Yearly Dividend Yield of 1.76%. Purely for dividend investing, there may be better candidates out there.
IVG's Dividend Yield is a higher than the industry average which is at 1.55.
Compared to an average S&P500 Dividend Yield of 1.94, IVG has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
27.33% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP27.33%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
BIT:IVG (1/9/2026, 5:35:30 PM)
18.825
+0 (+0.03%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.11B
Revenue(TTM)14.48B
Net Income(TTM)322.00M
Analysts72.31
Price Target20.11 (6.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-3.62%
EPS NY rev (3m)-13.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-3.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.05 | ||
| Fwd PE | 8.73 | ||
| P/S | 0.34 | ||
| P/FCF | 12.76 | ||
| P/OCF | 3.96 | ||
| P/B | 1.96 | ||
| P/tB | 9.25 | ||
| EV/EBITDA | 5.58 |
EPS(TTM)1.34
EY7.12%
EPS(NY)2.16
Fwd EY11.45%
FCF(TTM)1.47
FCFY7.83%
OCF(TTM)4.75
OCFY25.25%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.77 |
F-Score6
WACC7.28%
ROIC/WACC0.62
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year64.49%
EBIT Next 3Y27.62%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%
IVECO GROUP NV / IVG.MI FAQ
Can you provide the ChartMill fundamental rating for IVECO GROUP NV?
ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.
What is the valuation status for IVG stock?
ChartMill assigns a valuation rating of 5 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for IVECO GROUP NV?
IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.
How financially healthy is IVECO GROUP NV?
The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.
Can you provide the expected EPS growth for IVG stock?
The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -22.36% in the next year.